Pfizer Looking for Guinea Pigs to Trial New mRNA FLU Vaccine, Any Takers?
By Investment Watch Blog
Detailed Description:
This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a quadrivalent influenza modRNA vaccine (qIRV) encoding HA of 4 seasonally recommended strains (2 A strains and 2 B strains) compared to licensed quadrivalent influenza vaccine (QIV) in healthy adults 18 years of age and older.
Participants may be enrolled in either the reactogenicity subset, immunogenicity subset, or both subsets. Efficacy will be assessed in this study through surveillance for influenza-like illness.
If any guinea pig wants to volunteer to a delicious lunch for hungry wolves brought to you by @pfizer,hurry!
Recruiting:
HENRICO COUNTY,Clinical Research Partnershttps://t.co/Vwe1WpeqeF
Click "Show 275 study locations",search "Clinical Research Partners"https://t.co/nlq57VhuAl pic.twitter.com/CkeHaMwyc3— VaccineMole (@VaccineMole) April 10, 2023
Oh,in case you want to know the doctor being interviewed
His name's Dr. Bo Vaughan,medical director at company Clinical Research Partners,LLC
He doesn't reveal his sponsor
It happens his company will be trial site for new @Pfizer flu mRNA vaccine brought to you by @pfizer pic.twitter.com/cmuSDcpErK— VaccineMole (@VaccineMole) April 10, 2023
Original Source: https://www.investmentwatchblog.com/pfizer-looking-for-guinea-pigs-to-trial-new-mrna-flu-vaccine-any-takers/